Literature DB >> 2827804

Nuclear accumulation of a heat-shock 70-like protein during herpes simplex virus replication.

N B LaThangue1, D S Latchman.   

Abstract

A monoclonal antibody defines an antigen, p68, related to hsp70, which is located in nuclei of uninfected exponential cells. Nuclear p68 is released by DNase but not RNase treatment suggesting an association with DNA. Lytic productive infection of confluent quiescent BHK 21 cells with herpes simplex virus type-2 causes p68 to accumulate in nuclei. The effect is specific for HSV-2, and does not occur in HSV-1 infected cells. Maximum nuclear accumulation of p68 requires virus DNA synthesis although a significant accumulation occurs in the absence of such synthesis. It is suggested that the nuclear accumulation of p68 is an aspect of a cellular stress response to lytic infection with HSV-2.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2827804     DOI: 10.1007/BF01116504

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  4 in total

1.  Association of a cellular heat shock protein with simian virus 40 large T antigen in transformed cells.

Authors:  E T Sawai; J S Butel
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

Review 2.  Regulation of ligands for the NKG2D activating receptor.

Authors:  David H Raulet; Stephan Gasser; Benjamin G Gowen; Weiwen Deng; Heiyoun Jung
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

3.  Induction of cellular hsp70 expression by human cytomegalovirus.

Authors:  L D Santomenna; A M Colberg-Poley
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

Review 4.  New Insights Into the Regulation of Natural-Killer Group 2 Member D (NKG2D) and NKG2D-Ligands: Endoplasmic Reticulum Stress and CEA-Related Cell Adhesion Molecule 1.

Authors:  Shuhei Hosomi; Joep Grootjans; Yu-Hwa Huang; Arthur Kaser; Richard S Blumberg
Journal:  Front Immunol       Date:  2018-06-18       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.